These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7821321)

  • 1. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
    Thormann J; Mitrovic V; Strasser R; Pitschner HF; Riedel H; Bahavar H; Schlepper M
    Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
    Sedgwick ML; Rasmussen HS; Cobbe SM
    Am J Cardiol; 1992 Dec; 70(18):1432-7. PubMed ID: 1442614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.
    Ohler A; Ravens U
    J Pharmacol Exp Ther; 1994 Aug; 270(2):460-5. PubMed ID: 7520940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle.
    Yuan S; Wohlfart B; Rasmussen HS; Olsson S; Blomström-Lundqvist C
    Eur Heart J; 1994 Apr; 15(4):514-22. PubMed ID: 8070479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes.
    Wettwer E; Himmel HM; Amos GJ; Li Q; Metzger F; Ravens U
    Br J Pharmacol; 1998 Oct; 125(4):659-66. PubMed ID: 9831899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter.
    Hohnloser SH; Dorian P; Straub M; Beckmann K; Kowey P
    J Am Coll Cardiol; 2004 Jul; 44(1):99-104. PubMed ID: 15234416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Bril A; Landais L; Gout B
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.
    Wiesfeld AC; De Langen CD; Crijns HJ; Bel KJ; Hillege HL; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):594-600. PubMed ID: 8847879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.